Infectious mononucleosis is a more realistic target for preventing multiple sclerosis.

Gavin Giovannoni1, Christopher H Hawkes1, Jeannette Lechner-Scott2

  • 1Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.

Summary

Preventing Epstein-Barr virus (EBV) infection, particularly infectious mononucleosis (IM), through vaccination is key to preventing multiple sclerosis (MS). An EBV vaccine could significantly reduce MS incidence by targeting a necessary precursor infection.